The Cancer Letter

Company: The Cancer Letter

Description: The Cancer Letter an independent weekly news publication has been the leading source for information on the issues that shape oncology since 1973 The Cancer Letter provides authoritative awardwinning coverage of the development of cancer therapies drug regulation legislation cancer research funding health care finance and public health Our coverage focuses on the National Cancer Institute National Institutes of Health Food Drug Administration US Congress cancer centers and the pharmaceutical industry The Cancer Letters readers include key opinion leaders at academic institutions community oncology practices government agencies professional associations health IT and pharmaceutical companies Wall Street and advocacy organizations Based in Washington DC The Cancer Letter has earned acclaim for its investigative work It has been profiled and cited in outlets including The New York Times The Washington Post 60 Minutes CNN NPR Science and Nature Coverage by The Cancer Letter has triggered multiple investigations by Congressional committees the Institute of Medicine the Federal Trade Commission the Securities and Exchange Commission and the Department of Justice and contributed to federal action by the FDA the Centers for Disease Control and Prevention the Federal Bureau of Investigation and Government Accountability Office

Industry: Newspaper Publishing

LinkedIn: https://www.linkedin.com/company/the-cancer-letter

Domain: http://www.cancerletter.com/

Founded: 1973

Location: Washington, District of Columbia

Address: The Cancer Letter Inc., Washington, District of Columbia 20016, US

Size: 2-10 employees